Ane Appelt
banner
cancerphysicist.bsky.social
Ane Appelt
@cancerphysicist.bsky.social
Physicist, cancer & radiotherapy researcher, trialist, data nerd. Global low-carbon / train traveller. Occasional caver & underground photographer. Professor of Clinical Medical Physics at Rigshospitalet & DTU, Copenhagen, DK #radonc #medphys
That would be amazing! Tuesday morning works - just let me know when fits you 😊
July 26, 2025 at 12:37 AM
It was a pleasure! Thank you so much for keeping me company 😊 Hope the last leg is at least going smoothly - LNER did their job and got me onto another train, so now heading north to Leeds
May 7, 2025 at 3:47 PM
😂 😂 We had enough of an ESTRO contingent on the train that we could have reasonably brought her with us 😁

(Although … you were nominally the industry representative in the group. So wasn’t the coffee your responsibility?!?)
May 7, 2025 at 3:42 PM
Well, we’ve got as far as Brussels. Now waiting for the 14:52 Eurostar (after the staff kindly rebooked us). So only 2 hours delay so far, at least - but I’m really sad about missing out on a leisurely morning with breakfast on the train 🙁
May 7, 2025 at 12:13 PM
In terms of the response rate, I think that’s actually pretty good, given that it’s 6 months later and many of these patients were referred back to surgical departments etc, so lost contact with the RT department. And we didn’t use electronic questionnaires, so they had to get it in person
May 7, 2025 at 6:18 AM
Good questions, and maybe @beardy-econ.bsky.social is better placed to answer 😊 But no, they weren’t all treated identically - most were included in the APHRODITE trial, which ment that they were randomised between standard and dose escalated LCRT. But some were treated outside trial
May 7, 2025 at 6:15 AM
My feet are shattered by too much walking in heels, and I'm functioning on about 15 hours of sleep over the last five days. So now hanging out in a cool little cafe, trying to keep awake before boarding the night train to Brussels🚆
See you all in Stockholm next year #ESTRO25
May 6, 2025 at 4:30 PM
This was also my very first conference with my partner attending - and we even had a joint study to present 😊 bsky.app/profile/canc...
How do patients prioritise different aspects of non-operative rectal cancer treatment?

We conducted a prospective, longitudinal multicentre study alongside a clinical trial, asking rectal cancer patients undergoing definitive RT to help us understand their treatment preferences
#ESTRO25 #RadOnc
Off to my first #ESTRO 2025 session today!

Here's our poster, a DCE on preferences for non-surgical rectal cancer treatment. We found:

- patients accepted more toxicity for a greater chance of cure
- long-term side effects more important than short-term
- preferences stable pre/post-treatment
May 6, 2025 at 4:30 PM
I gave a total of 5 talks, attended & chaired numerous meetings, made it to too few of the scientific talks (🙏 online recordings!), and saw so many friends and colleagues that I have lost count a long time ago. I even managed to meet a few new people (@NiuSanford!) #ESTRO25
May 6, 2025 at 4:30 PM
I got to catch up with my partner in crime (i.e. all things #reirradiation) Eliana Vasquez Osorio, who gave a brilliant - as always - talk on image registration for reRT dose accumulation today #radonc #medphys #ESTRO25
May 6, 2025 at 4:30 PM
We got to present our innovative #reirradiation treatment planning solution, developed in close collaboration with RaySearch - and we saw the near-final implementation in RayStation. I can't believe that this may soon be available for clinical treatments! bsky.app/profile/canc...
Things that make me happy:
Seeing an RT planning & evaluation solution for #reirradiation that I’ve helped develop in its (nearly) final version. Amazing work by @raysearchlabs.bsky.social @solstina.bsky.social @crukradnetleeds.bsky.social & colleagues.
Probably highlight of #ESTRO25 so far for me 😍
May 6, 2025 at 4:30 PM
#ESTRO25 was dominated by #reirradiation for me: invited talks, collaborators w/ presentations, Physics ReRT Working Group meeting, launch of the multidisciplinary ESTRO ReRT Focus Group, lunchtime meet&greet, rectal cancer reRT guidelines & more bsky.app/profile/canc...
Love it when a plan comes together! This year’s joint #ESTRO25-AAPM symposium is the culmination of 3 years of cross-Atlantic #reirradiation collaboration🤩
🔹Chuck Mayo: #medphys-led workflows
🔹Søren Bentzen: #radbio
🔹Marija Popovic: dose accumulation
🔹Lone Hoffmann: reRT trial design & QA
May 6, 2025 at 4:30 PM
The lower GI clinical trials sessions were packed with groundbreaking findings: primary reporting from STAR-TREC, PLATO ACT 4, PRIME-RT, STELLAR II, CAO/ARO/AIO-16, and more
bsky.app/profile/canc...
No other scientific meeting has this high level of #radonc trial & research!
I’m SO delighted to finally see first STAR-TREC data reported 🤩 #ESTRO25

Short course RT vs chemorad for organ preservation in early stage rectal cancer

61% vs 80% TME-free survival at 12 months ➡️ More organ preservation with long-course chemorad!
#radonc #rectalcancer
May 6, 2025 at 4:30 PM
I couldn't agree more. We need more patient involvement - and we need it to not be confined to the last Tuesday session! I couldn't make it (speaking at the same time ...), but it looks like it was an excellent session - can't wait to catch up on the recording #ESTRO25
May 6, 2025 at 2:36 PM